• head_banner_01

Super Purchasing for Cetylpyridinium Chloride - Liraglutide Anti-Diabetics for Blood Sugar Control CAS NO.204656-20-2 – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

It is a great way to further improve our products and repair. Our mission is always to create innovative products to prospects with a superior expertise for Choline Acetate, Liraglutide, 2,6-Dihydroxy-3-Cyano-4-Methyl Pyridine, Being a young growing company, we might not the best, but we are trying our best to be your good partner.
Super Purchasing for Cetylpyridinium Chloride - Liraglutide Anti-Diabetics for Blood Sugar Control CAS NO.204656-20-2 – Gentolex Detail:

Product Detail

CAS 204656-20-2 Molecular Formula C172H265N43O51  
Molecular Weight 3751.20 Appearance White
Storage Condition Light resistance, 2-8 degree Package Aluminum foil bag/vial
Purity ≥98% Transportation Cold Chain and cool storage delivery

Ingredients of Liraglutide

Application

Type 2 diabetes

Liraglutide improves control of blood glucose. It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion.
It is suitable for patients whose blood sugar is still poorly controlled after the maximum tolerated dose of metformin or sulfonylureas alone. It is used in combination with metformin or sulfonylureas.
It acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing “overshoot”. Consequently, it shows negligible risk of hypoglycemia.
It has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies).
It decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride.

Pharmacological Action

Liraglutide is a GLP-1 analog with 97% sequence homology to human GLP-1, which can bind to and activate the GLP-1 receptor. The GLP-1 receptor is the target of native GLP-1, an endogenous incretin hormone that promotes glucose concentration-dependent insulin secretion from pancreatic β cells. Unlike native GLP-1, the pharmacokinetic and pharmacodynamic profiles of liraglutide in humans are suitable for a once-daily dosing regimen. After subcutaneous injection, its mechanism of prolonged action includes: self-association that slows absorption; binding to albumin; Higher enzyme stability and thus longer plasma half-life.

The activity of liraglutide is mediated by its specific interaction with the GLP-1 receptor, resulting in an increase in cyclic adenosine monophosphate (cAMP). Liraglutide stimulates insulin secretion in a glucose concentration-dependent manner, while reducing excess glucagon secretion in a glucose concentration-dependent manner.

Therefore, when blood glucose rises, insulin secretion is stimulated, while glucagon secretion is inhibited. In contrast, liraglutide reduces insulin secretion during hypoglycemia without affecting glucagon secretion. The hypoglycemic mechanism of liraglutide also includes a slight prolongation of gastric emptying time. Liraglutide reduces body weight and body fat mass by reducing hunger and energy intake.


Product detail pictures:

Super Purchasing for Cetylpyridinium Chloride - Liraglutide Anti-Diabetics for Blood Sugar Control CAS NO.204656-20-2 – Gentolex detail pictures


Related Product Guide:

Our products are broadly regarded and reliable by end users and can meet up with constantly transforming financial and social requires of Super Purchasing for Cetylpyridinium Chloride - Liraglutide Anti-Diabetics for Blood Sugar Control CAS NO.204656-20-2 – Gentolex , The product will supply to all over the world, such as: Azerbaijan, South Africa, Manila, We have now a good reputation for stable quality goods, well received by customers at home and abroad. Our company would be guided by the idea of "Standing in Domestic Markets, Walking into International Markets". We sincerely hope that we could do business with car manufacturers, auto part buyers and the majority of colleagues both at home and abroad. We expect sincere cooperation and common development!
  • The product classification is very detailed that can be very accurate to meet our demand, a professional wholesaler.
    5 Stars By Carlos from Luxembourg - 2017.11.01 17:04
    It is a very good, very rare business partners, looking forward to the next more perfect cooperation!
    5 Stars By Alex from Singapore - 2018.10.31 10:02
    Write your message here and send it to us